Polycythemia
8
4
4
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (8)
Molecular Biology of Polycythemia and Thrombocytosis
129Xe MRI Cardiopulmonary
Potential Biological and Physiological Determinants for Exercice in Patients With Polycythemia Vera
CO-Rebreathing in Comparison to Isotopic Red Cell Volume Determination in the Diagnosis of Primitive and Secondary Polycythemia
CPAP Effect on the Polycythemia in Patients With Obstructive Sleep Apnea
EVAluation of Erythrocytosis PRospEctive Cohort STudy
Effect of Phlebotomy on Heartrate in Polycythemia Patients
Late Gestational Diabetes Mellitus Diagnosis in Obese Women